Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01179191 · ClinicalTrials.gov registry record · Phase 4
Conversion to Embeda With Rescue Trial
A Phase 4 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 4
- Development phase
- 684
- Enrollment target
NCT01179191 is a Phase 4 study that was terminated before completion, run by Pfizer. The registered enrollment target is 684 participants.
The verdict
NCT01179191, a Phase 4 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 684 participants
- Enrollment target
Study Summary
The purpose of the research study is to find out if opioid dependent chronic pain patients who are judged by their physician to be eligible to change their current opioid medicine and to participate in this study can be successfully adjusted to a stable dose of EMBEDA (morphine sulfate and naltrexone hydrochloride). The study will also assess each patient's risk for prescription opioid abuse, misuse and diversion.
Interventions
- DRUG morphine sulfate and naltrexone hydrochloride (EMBEDA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 684 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01179191
The ClinicalTrials.gov registry entry for NCT01179191 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 684 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which morphine sulfate and naltrexone hydrochloride (EMBEDA) is the first listed.
NCT01179191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01179191 about?
NCT01179191 is a clinical study titled "Conversion to Embeda With Rescue Trial". The purpose of the research study is to find out if opioid dependent chronic pain patients who are judged by their physician to be eligible to change their current opioid medicine and to participate in this study can be successfully adjusted to a stable dose of EMBEDA (morphine sulfate and naltrexon...
What is the current status of trial NCT01179191?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 684 participants. The study started on 2010-08. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01179191?
The interventions under investigation include: morphine sulfate and naltrexone hydrochloride (EMBEDA) (DRUG).
Who is sponsoring clinical trial NCT01179191?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.